| Literature DB >> 29227529 |
Hongping Lu1,2, Ming Han1,2,3, Xiaoxue Yuan1,2, Kelbinur Tursun2,4, Yu Zhang1,2, Yaru Li1,2, Zhongshu Li1,2, Shenghu Feng2,3, Li Zhou2,3, Zhipeng Pan2,5, Qi Wang1,2, Kai Han1,2, Shunai Liu1,2, Jun Cheng1,2,3.
Abstract
This study aimed to investigate the relationship between interleukin-6 (IL-6) and NS5ATP9 in autophagy of liver cancer cells. Autophagy is one of the important regulators of the replication of hepatitis C virus and the survival of tumors. IL-6 is a multifunctional cytokine that plays an important role in autophagy and development of many kinds of tumors. However, the role of IL-6 in autophagy has not been fully explored. A previous study had shown that a novel gene, NS5ATP9, could modulate autophagy. The present study demonstrated that human IL-6 recombinant protein induced autophagy of HepG2 cells. Conversely, autophagy decreased after IL-6 was silenced or neutralized with monoclonal antibody against human IL-6. In addition, NS5ATP9 was upregulated by IL-6 via nuclear factor-kappaB activation, as detected by Western blot. Further studies indicated that the induction of autophagy by IL-6 could be attenuated by silencing NS5ATP9. Interestingly, the expression of NS5ATP9, in turn, resulted in the upregulation of IL-6. In conclusion, IL-6 could induce autophagy by expressing NS5ATP9, while NS5ATP9 upregulated IL-6 levels in turn, which further induced autophagy.Entities:
Keywords: IL-6; NS5ATP9; autophagy; hepatocellular carcinoma; microenvironment
Mesh:
Substances:
Year: 2018 PMID: 29227529 DOI: 10.1002/jcp.26343
Source DB: PubMed Journal: J Cell Physiol ISSN: 0021-9541 Impact factor: 6.384